Group 1 - The company, Zhongwang Software (688083.SH), announced an expected net profit attributable to shareholders of the parent company for the year 2025 to be between 16 million and 24 million yuan [1] - This represents a decrease of 39.9643 million to 47.9643 million yuan compared to the same period last year, indicating a year-on-year decline of 62.48% to 74.99% [1]

Group 1 - The company, Kemei Diagnostics (688468.SH), announced an expected net profit attributable to shareholders of the parent company for the year 2025 to be between 40 million to 48 million yuan, which represents a year-on-year decrease of 62.23% to 68.52% compared to the previous year [1]

Core Viewpoint - The company expects a significant decrease in net profit for the first half of 2025, projecting a net profit of 29.90 million yuan, which represents a 32.91% decline compared to the same period last year [1] Financial Performance - The net profit attributable to shareholders and the net profit after deducting non-recurring gains and losses are both expected to decrease compared to the same period last year [1] - The decrease in net profit is primarily attributed to an increase in overseas sales freight and commissions by approximately 11 million yuan [1] - A sharp appreciation of the New Taiwan Dollar against the US Dollar by 11.76% in the second quarter resulted in foreign exchange losses of about 7.68 million yuan from overseas accounts receivable [1] - Additionally, the increase in testing fees for recoverable product research and development amounted to approximately 5.72 million yuan, further contributing to the decline in net profit [1]